ADVAIR - 0173-0696-04 - (fluticasone propionate and salmeterol)

Alphabetical Index


Drug Information of ADVAIR

Product NDC: 0173-0696
Proprietary Name: ADVAIR
Non Proprietary Name: fluticasone propionate and salmeterol
Active Ingredient(s): 250; 50    ug/1; ug/1 & nbsp;   fluticasone propionate and salmeterol
Administration Route(s): RESPIRATORY (INHALATION)
Dosage Form(s): POWDER
Coding System: National Drug Codes(NDC)

Labeler Information of ADVAIR

Product NDC: 0173-0696
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021077
Marketing Category: NDA
Start Marketing Date: 20010205

Package Information of ADVAIR

Package NDC: 0173-0696-04
Package Description: 14 POWDER in 1 INHALER (0173-0696-04)

NDC Information of ADVAIR

NDC Code 0173-0696-04
Proprietary Name ADVAIR
Package Description 14 POWDER in 1 INHALER (0173-0696-04)
Product NDC 0173-0696
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name fluticasone propionate and salmeterol
Dosage Form Name POWDER
Route Name RESPIRATORY (INHALATION)
Start Marketing Date 20010205
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Strength Number 250; 50
Strength Unit ug/1; ug/1
Pharmaceutical Classes Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]

Complete Information of ADVAIR


General Information